VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
VEGF-A drives T cell exhaustion via TOX-dependent transcriptional programming in microsatellite stable colorectal cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies have demonstrated that VEGF blockade can reverse T cell failure and enhance the therapeutic effect of ICI [59,60].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [60]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791 · cited 1×
“INTRODUCTION Tumor antigen–specific T cells within the tumor microenvironment are exhausted, and their antitumor functions are substantially impaired (1, 2).”
BackgroundMismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationPrimary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
Cited by
Items 201–250 of 250
High Expression of ISYNA1 Preidicts Unfavourable Prognosis in Patients with Colorectal CancerPreprint
Wang, X., Ye, Z., Zeng, Y., Wang, Y., Wei, S., Lin, Z., Chen, S., Chen, H., Wang, Z., Lin, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1263640/v1
Li, Z., Zhang, Y., Pei, J., Xu, Z., Chen, H., & Huang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1973956/v1
Potential Biomarkers in Drug-Resistant Colorectal Cancer Cells
Li, D., Jin, L., Wang, M., Chen, J., Xia, C., & Chen, C. (2022) · Annals of Medical and Clinical Oncology · doi:10.29011/2833-3497.000142
Gumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W. J., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2023) · BMC Research Notes · doi:10.1186/s13104-023-06283-5
310 Targeted delivery of a VEGF-blocking scFv to enhance CAR-T cell potency
Supper, V. M., Donner, H., Kann, M. C., Birocchi, F., Korell, F., Salas‐Benito, D., Bailey, S. R., Kienka, T., Philips, M., Haradhvala, N. J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-sitc2023.0310
A New Hope? Combination Immunotherapy for Microsatellite Stable Colorectal Cancer
Qian, X., Jia, C., Kong, F., & Jia, Y. (2024) · Med Discoveries · doi:10.52768/2993-1142/1099
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21798-2.16001-4
Wang, Y., Su, P., Lu, Q., Huang, H., & Li, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4933597/v1
Impact de l'hépatocyte growth factor sur les lymphocytes T régulateurs dans le cancer gastrique
Palle, J. (2023) · theses.fr (ABES) · doi:10.70675/0951fdc8zcb07z41bcz8559z8c45d4215dc0
Gumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26569132
Chen, Z., Zhang, M., Liu, Y., Chen, Z., Wang, L., Wang, W., Wang, J., He, M., Shi, B., & Wang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26566085
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561060
Self-citationKim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561033
Self-citationGumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26569135
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561042
Self-citationKim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561039
Self-citationGumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26569129
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561048
Self-citationGumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26569138
Gumbleton, M., Allan, S., Conway, H., Boucher, K. M., Marvin, J., Hawks, J., Burnett, W., Brocklin, M. W. V., Whisenant, J. R., Gilcrease, G. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26569126
Zhao, Y., Liao, P., Huang, S., Deng, T., Tan, J., Huang, Y., Zhan, H., Li, Y., Chen, S., & Zhong, L. (2022) · Figshare · doi:10.6084/m9.figshare.19311589
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561045
Self-citationKim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561054
Self-citationKim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561051
Self-citationChen, Z., Zhang, M., Liu, Y., Chen, Z., Wang, L., Wang, W., Wang, J., He, M., Shi, B., & Wang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26566088
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561057
Self-citationKim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561036
Self-citationZhao, Y., Liao, P., Huang, S., Deng, T., Tan, J., Huang, Y., Zhan, H., Li, Y., Chen, S., & Zhong, L. (2022) · Figshare · doi:10.6084/m9.figshare.19311595
Kim, C. G., Kim, M. H., Kim, J. H., Kim, S.-G., Kim, G. M., Kim, T. Y., Ryu, W.-J., Kim, J. Y., Park, H. S., Park, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26561063
Self-citationShao, Y., Zhang, Z., Wang, Y., Zhang, C., Liu, E., & Yu, H. (2026) · Targetome · doi:10.48130/targetome-0025-0012
RUNX1 restrains STAT1-GITRL signaling to shape an immunosuppressive CRC microenvironment
He, W., Zheng, L., Huang, W., Li, K., Chen, Y., Zeng, R., Lin, Z., Xu, Y., Hu, S., & Zhang, Q. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03053-7 · Cited by 1
Jin, Z., Zhang, L., Zheng, C., Yang, F., Hao, N., Mao, L., Chi, B., Liu, Y., Sun, P., Zheng, N., et al. (2026) · European Radiology · doi:10.1007/s00330-026-12502-x
“Microsatellite stable (MSS) or pro fi cient mismatch repair (pMMR) tumors, which represent the majority, respond poorly to ICIs [7].”
Danlos, F. (2021) · theses.fr (ABES) · doi:10.70675/ff8cb58bzc391z43f8zbd32zc8c4b2cdc725
Anti-Tumor Immunity in Solid-Organ Transplant Recipients
Wong, J. S. L., Li, K. H. L., Li, B., Leung, R. C., Yap, D. Y. H., Chan, A. C. Y., Cheung, T.-T., & Yau, T. C. C. (2026) · Cancers · doi:10.3390/cancers18081216
Kim, W., Kim, J. E., Hong, Y. S., Hwang, D. W., Kim, J., Lee, J. S., Shin, J.-H., Kim, T. W., Nagarkar, D., Byrd, A. L., et al. (2026) · Genome Medicine · doi:10.1186/s13073-026-01680-4
“These findings are consistent with those of previous studies, showing that VEGF pathways play a major role in immune resistance in MSS CRC [22, 23].”
Self-citationImmunomodulatory Effects of Anti-Angiogenic Drugs and Their Combination with Immunotherapy
Moro, M., & Grolla, A. A. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1015471
TOX enforces the immunosuppressive program of tumor-infiltrating regulatory T cellsPreprint
Park, S.-J., Park, D. J., Kim, M. J., Kelly, G., Zhang, R., Kim, G., Jeong, J., Kim‐Schulze, S., Kim, H. R., Kim, K. I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.19.732838
Self-citationZhang, Z., Gu, Y., Qiao, S., Sang, L., Zhang, L., & Zhou, F. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100056 · Cited by 2
Lorestani, P., Robat-Jazi, B., Nejati, N., Jazi, K., Faghihkhorasani, F., Khalili, A., Karimizadeh, Z., Kalantari, A., Mirsharifi, E., Hojjat, S. H., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05539-3
“These results inform the development of dual VEGF and ICIs for GI cancers and provide a mechanistic foundation for positive outcomes observed in clinical trials like REGONIVO and IMbrave150 [213, 223].”
Andresyuk, E. A., Porozova, N. O., Londaridze, G. D., Moiseev, I., Kotselyabina, P. V., & Porozov, Y. B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1875861
Nwadozi, E., Strell, C., Nordling, S., Lindberg, A., Backman, M., Cosmen, P. D., Marwitz, S., Goldmann, T., Isaksson, J., Botling, J., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218728 · Cited by 2
Cheng, H., Chen, M., Xiao, M., Zhang, H., Zhang, Z., Jiang, D., Wan, A. H., Wang, Q., & Wan, G. (2026) · Biomedicines · doi:10.3390/biomedicines14091955
“In anti-PD-1-resistant microsatellite-stable colorectal cancer, vascular endothelial growth factor A has also been linked to thymocyte selection-associated high mobility group box (TOX)-dependent T-cell exhaustion [37].”
Heterotypic tumor microenvironments mirror dynamic wound-healing process
Yu, L., & Zhang, X. H.-F. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.08.007
Li, K., Qian, Z., Mao, J., Han, Y., & Leng, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08945-x
Zuccolotto, G., Borghese, L., Rebuli, A., Rosato, A., & Tosi, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1957165
Cong, Y., Ma, Z., Zhong, K., Bao, Y., Lei, S., Qiao, P., Aji, T., & Shao, Y. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s638869
“25,26 In this setting, TOX should be viewed as one node in a network that integrates antigenic stimulation, chromatin remodeling, and environmental stress.”
Jeon, J., Baek, H. S., Park, K., Park, M., Heo, N. H., Cheon, S., Kim, G., & Kim, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209134
“In an MC38 syngeneic colon tumor model, pharmacological NR4A1 antagonism reduced exhaustion-associated markers and enhanced effector function [179], whereas vascular endothelial growth factor A (VEGF-A) and IDO1-derived kynurenine promote TOX-associated T-cell exhaustion in CRC [180,181].”
Bispecific antibodies in NSCLC: immune reengineering to neutralize adaptive tumor resistance
Li, Z., Wang, H., Diao, M., Liu, R., Wang, X., Xiong, A., Zhou, C., & Tang, Z. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.09.010
Mapping the molecular overlap between CD8+ T cell tolerance and exhaustion
Deguit, C. D. (2025) · Minerva Access (University of Melbourne)
Metadata
- Authors
- Kim, C. G., Jang, M., Kim, Y., Leem, G., Kim, K. H., Lee, H., Kim, T.-S., Choi, S. J., Kim, H.-D., Han, J. W., Kwon, M., Kim, J. H., Lee, A. J., Nam, S. K., Bae, S.-J., Lee, S. B., Shin, S. J., Park, S. H., Ahn, J. B., Jung, I., Lee, K. Y., Park, S.-H., Kim, H., Min, B. S., & Shin, E.-C.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- Yonsei University (KR)
- Corresponding author
- Kim, Chang Gon
- Jang, Mi
- Kim, Hoguen
- Min, Byung Soh
- Shin, Eui-Cheol
- ORCID
- Kim, Chang Gon
- Jang, Mi
- Kim, Youngun
- Leem, Galam
- Kim, Kyung Hwan
- Lee, Hoyoung
- Kim, Tae-Shin
- Choi, Seong Jin
- Kim, Hyung-Don
- Han, Ji Won
- Kwon, Minsuk
- Kim, Jong Hoon
- Lee, Andrew J.
- Nam, Su Kyung
- Bae, Seok-Joo
- Lee, Sat Byol
- Shin, Sang Joon
- Park, Sung Ho
- Ahn, Joong Bae
- Jung, Inkyung
- Lee, Kang Young
- Park, Su-Hyung
- Kim, Hoguen
- Min, Byung Soh
- Shin, Eui-Cheol
- Venue
- Science Immunology
- Published
- 2019-11
- Volume
- 4
- Issue
- 41
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2989029645
- Cited by
- 245
- References
- 67
- Citations by year
- 2026: 29 · 2025: 25 · 2024: 45 · 2023: 32 · 2022: 46 · 2021: 43 · 2020: 24 · 2019: 1
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Funders
- Ministry of Science and ICT (NRF-2018M3A9D3079498)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- VEGF-A, TOX transcription factor, T cell exhaustion, anti-PD-1 resistance, microsatellite stable colorectal cancer, immune checkpoint blockade, tumor-infiltrating T cells, antitumor immunity
- MeSH terms
- Animals, High Mobility Group Proteins, Humans, Mice, Inbred C57BL, T-Lymphocytes, Colorectal Neoplasms, Homeodomain Proteins, Microsatellite Repeats, Caco-2 Cells, Vascular Endothelial Growth Factor A, Mice, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.